{"id":5987,"date":"2025-03-27T06:32:00","date_gmt":"2025-03-27T11:32:00","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=5987"},"modified":"2025-07-13T15:09:52","modified_gmt":"2025-07-13T20:09:52","slug":"ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/es\/2025\/03\/27\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\/","title":{"rendered":"El veterano de la industria farmac\u00e9utica, Ashish Patel, PhD, se une a Nanoscope como vicepresidente s\u00e9nior de ventas y marketing."},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"5987\" class=\"elementor elementor-5987\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-a820957 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"a820957\" data-element_type=\"section\" data-e-type=\"section\">\r\n\t\t\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\r\n\t\t\t\t\r\n\t\t\t\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-4be7a92f\" data-id=\"4be7a92f\" data-element_type=\"column\" data-e-type=\"column\">\r\n\r\n\t\t\t\t\r\n\t\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\r\n\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6acdc6c4 elementor-widget elementor-widget-text-editor\" data-id=\"6acdc6c4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>DALLAS, 27 de marzo de 2025 \u2014 <a href=\"http:\/\/nanostherapeutics.com\/es\/\">Nanoscopio Therapeutics Inc<\/a>.Una empresa de biotecnolog\u00eda dedicada a restaurar la visi\u00f3n en personas ciegas o que la est\u00e1n perdiendo debido a diversas enfermedades degenerativas de la retina, anunci\u00f3 hoy que Ashish Patel, PhD, se ha unido a la compa\u00f1\u00eda como Vicepresidente S\u00e9nior de Ventas y Marketing. El Dr. Patel es un l\u00edder reconocido con una trayectoria comprobada en la gesti\u00f3n de marcas, ventas e investigaci\u00f3n y desarrollo para algunas de las empresas emergentes de biotecnolog\u00eda y farmac\u00e9uticas m\u00e1s reconocidas del mundo.<\/p><div class=\"col-sm-4 col-xs-12 col-vcenter\"><div class=\"image logo logo-wrapper\" data-src=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=publish\" data-asset-type=\"photo\" data-asset-label=\"Logo\" data-download-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg\" data-tweet-text=\"Nanoscope Therapeutics Logo (PRNewsfoto\/Nanoscope Therapeutics)\" data-pinterest-text=\"Nanoscope Therapeutics Logo (PRNewsfoto\/Nanoscope Therapeutics)\" data-linkedin-text=\"Nanoscope Therapeutics Logo (PRNewsfoto\/Nanoscope Therapeutics)\" data-facebook-share-text=\"Nanoscope Therapeutics Logo (PRNewsfoto\/Nanoscope Therapeutics)\" data-twitter-share-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=twitter\" data-facebook-share-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=facebook\" data-pinterest-share-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=publish\" data-linkedin-share-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=linkedin\"><p>\u201cCon su singular combinaci\u00f3n de experiencia cient\u00edfica y comercial, particularmente en el tratamiento de enfermedades de la retina, el Dr. Patel est\u00e1 bien preparado para impulsar la estrategia de ventas y marketing de Nanoscope a medida que avanzamos hacia la comercializaci\u00f3n de nuestras terapias optogen\u00e9ticas\u201d, dijo\u00a0<span class=\"xn-person\">Sulagna Bhattacharya<\/span>, cofundador y director ejecutivo de Nanoscope Therapeutics.<\/p><p>El Dr. Patel cuenta con una amplia experiencia en la alineaci\u00f3n de conocimientos cient\u00edficos y comerciales para fundamentar decisiones estrat\u00e9gicas y empresariales centradas en los pacientes. Recientemente, se desempe\u00f1\u00f3 como Vicepresidente de Ventas de Iveric Bio (ahora Astellas), donde lanz\u00f3 IZERVAY\u2122, un tratamiento para la atrofia geogr\u00e1fica. Antes de Iveric, el Dr. Patel lider\u00f3 las iniciativas de marketing y lanzamiento de BEOVU\u00ae de Novartis, utilizado para tratar afecciones oculares cr\u00f3nicas, incluida la degeneraci\u00f3n macular h\u00fameda relacionada con la edad (DMAE). Su trayectoria en Bayer abarc\u00f3 m\u00e1s de una d\u00e9cada, durante la cual desempe\u00f1\u00f3 diversos cargos de gesti\u00f3n de marca, ventas e investigaci\u00f3n. Cabe destacar que fue el responsable del lanzamiento global de la indicaci\u00f3n de mayor crecimiento dentro del exitoso negocio de retina EYLEA\u00ae de Bayer. Inici\u00f3 su carrera como cient\u00edfico s\u00e9nior de investigaci\u00f3n y desarrollo en Novartis.<\/p><p>El Dr. Patel recibi\u00f3 una Maestr\u00eda en Administraci\u00f3n de Empresas de\u00a0<span class=\"xn-org\">Universidad de Nueva York<\/span>\u00a0Stern School of Business y tiene un doctorado en fisiolog\u00eda y biof\u00edsica de la Universidad de Stony Brook. El Dr. Patel fue investigador de posgrado en biolog\u00eda molecular en la\u00a0<span class=\"xn-org\">Instituto Tecnol\u00f3gico de Massachusetts<\/span>\u00a0y obtuvo su Licenciatura en Ciencias en Biof\u00edsica de la Universidad del Sur de California.<\/p><p>\u201cNanoscope est\u00e1 a punto de convertirse en la primera empresa en ofrecer terapias innovadoras e independientes de mutaciones a pacientes con las mayores necesidades no cubiertas en el \u00e1rea de la retina\u201d, declar\u00f3 el Dr. Patel. \u201cMe entusiasma unirme al talentoso equipo de Nanoscope y espero contribuir a liderar la comercializaci\u00f3n y los preparativos para el lanzamiento, a medida que avanzamos en nuestra misi\u00f3n de ayudar a los millones de pacientes en todo el mundo afectados por enfermedades degenerativas de la retina para las que actualmente no existe tratamiento\u201d.\u201d<\/p><p><b>Acerca de Nanoscope Therapeutics Inc.<br class=\"dnr\" \/><\/b>Nanoscope Therapeutics est\u00e1 desarrollando terapias optogen\u00e9ticas, independientes de las mutaciones y que restauran la visi\u00f3n, para los millones de pacientes con ceguera causada por enfermedades degenerativas de la retina para las que actualmente no existe tratamiento. Tras los resultados positivos al final del estudio RESTORE, ensayo cl\u00ednico multic\u00e9ntrico, aleatorizado, doble ciego y controlado con placebo de fase 2b para la RP (<a href=\"https:\/\/clinicaltrials.gov\/study\/NCT04945772\" target=\"_blank\" rel=\"nofollow noopener\">NCT04945772<\/a>), la compa\u00f1\u00eda anunci\u00f3 su plan de iniciar un\u00a0<a href=\"https:\/\/mmh.a60.myftpupload.com\/2024\/10\/10\/nanoscope-announces-plans-to-submit-bla-for-mco-010-to-treat-retinitis-pigmentosa\/\" target=\"_blank\" rel=\"nofollow noopener\">Presentaci\u00f3n de BLA para MCO-010 para tratar RP<\/a>\u00a0en el primer semestre de 2025. La empresa ha completado el ensayo STARLIGHT de fase 2 de la terapia MCO-010 en pacientes con Stargardt (<a href=\"https:\/\/clinicaltrials.gov\/study\/NCT05417126\" target=\"_blank\" rel=\"nofollow noopener\">NCT05417126<\/a>) y planea iniciar una\u00a0<a href=\"https:\/\/mmh.a60.myftpupload.com\/2024\/09\/12\/nanoscope-therapeutics-announces-end-of-phase-2-meeting-with-u-s-fda-and-plan-to-initiate-a-phase-3-clinical-trial-of-mco-010-to-treat-stargardt-macular-degeneration\/\" target=\"_blank\" rel=\"nofollow noopener\">Ensayo de registro de fase 3<\/a>Tambi\u00e9n en el primer semestre de 2025, MCO-010 ha recibido las designaciones de v\u00eda r\u00e1pida de la FDA y de medicamento hu\u00e9rfano de la FDA tanto para RP como para Stargardt. Los programas precl\u00ednicos incluyen un activo MCO-020 de administraci\u00f3n l\u00e1ser no viral, listo para IND, para AG, as\u00ed como un activo AAV para la amaurosis cong\u00e9nita de Leber, en estudios que facilitan IND.<\/p><p><b>Contacto de inversores:<\/b><br class=\"dnr\" \/>Socios Argot<br class=\"dnr\" \/>212-600-1902\u00a0<br class=\"dnr\" \/><a href=\"mailto:PR@nanostherapeutics.com\" target=\"_blank\" rel=\"nofollow noopener\">PR@nanostherapeutics.com<\/a><\/p><p>FUENTE Terap\u00e9utica del Nanoscopio<\/p><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t<\/section>\r\n\t\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>DALLAS, March 27, 2025 \u2014 Nanoscope Therapeutics Inc., a biotech company committed to restoring vision in individuals who are blind or losing vision due to various retinal degenerative diseases, today announced that Ashish Patel, PhD, has joined the company as Senior Vice President, Sales and Marketing. Dr. Patel is a recognized leader with proven results [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":5988,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-5987","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pharmaceutical Industry Veteran, Ashish Patel, PhD, Joins Nanoscope as Senior Vice President of Sales and Marketing - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/es\/2025\/03\/27\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmaceutical Industry Veteran, Ashish Patel, PhD, Joins Nanoscope as Senior Vice President of Sales and Marketing - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/es\/2025\/03\/27\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-27T11:32:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-13T20:09:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_Ashish_V2_REV.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_Ashish_V2_REV.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/27\\\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/27\\\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Pharmaceutical Industry Veteran, Ashish Patel, PhD, Joins Nanoscope as Senior Vice President of Sales and Marketing\",\"datePublished\":\"2025-03-27T11:32:00+00:00\",\"dateModified\":\"2025-07-13T20:09:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/27\\\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\\\/\"},\"wordCount\":530,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/27\\\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_LI_Ashish_V2_REV.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/27\\\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/27\\\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\\\/\",\"name\":\"Pharmaceutical Industry Veteran, Ashish Patel, PhD, Joins Nanoscope as Senior Vice President of Sales and Marketing - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/27\\\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/27\\\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_LI_Ashish_V2_REV.jpg\",\"datePublished\":\"2025-03-27T11:32:00+00:00\",\"dateModified\":\"2025-07-13T20:09:52+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/27\\\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/27\\\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/27\\\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_LI_Ashish_V2_REV.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_LI_Ashish_V2_REV.jpg\",\"width\":1200,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/03\\\/27\\\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmaceutical Industry Veteran, Ashish Patel, PhD, Joins Nanoscope as Senior Vice President of Sales and Marketing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ashish Patel, doctor en filosof\u00eda y veterano de la industria farmac\u00e9utica, se une a Nanoscope como vicepresidente s\u00e9nior de ventas y marketing de Nanoscope Therapeutics.","description":"Nuestra plataforma de opsina multicaracter\u00edstica (MCO) es la primera en demostrar, en ensayos cl\u00ednicos, la capacidad de restaurar la visi\u00f3n en pacientes con enfermedades retinianas y p\u00e9rdida visual severa. Nanoscope ha desarrollado MCO-010, la primera y \u00fanica tecnolog\u00eda optogen\u00e9tica de amplio espectro, respuesta r\u00e1pida y ultrasensible para la restauraci\u00f3n de la visi\u00f3n, independiente del gen.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/es\/2025\/03\/27\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\/","og_locale":"es_MX","og_type":"article","og_title":"Pharmaceutical Industry Veteran, Ashish Patel, PhD, Joins Nanoscope as Senior Vice President of Sales and Marketing - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/es\/2025\/03\/27\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2025-03-27T11:32:00+00:00","article_modified_time":"2025-07-13T20:09:52+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_Ashish_V2_REV.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_image":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_Ashish_V2_REV.jpg","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"Escrito por":"Nanoscope Therapeutics","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2025\/03\/27\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/27\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Pharmaceutical Industry Veteran, Ashish Patel, PhD, Joins Nanoscope as Senior Vice President of Sales and Marketing","datePublished":"2025-03-27T11:32:00+00:00","dateModified":"2025-07-13T20:09:52+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/27\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\/"},"wordCount":530,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/27\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_Ashish_V2_REV.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2025\/03\/27\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\/","url":"https:\/\/nanostherapeutics.com\/2025\/03\/27\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\/","name":"Ashish Patel, doctor en filosof\u00eda y veterano de la industria farmac\u00e9utica, se une a Nanoscope como vicepresidente s\u00e9nior de ventas y marketing de Nanoscope Therapeutics.","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/27\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/27\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_Ashish_V2_REV.jpg","datePublished":"2025-03-27T11:32:00+00:00","dateModified":"2025-07-13T20:09:52+00:00","description":"Nuestra plataforma de opsina multicaracter\u00edstica (MCO) es la primera en demostrar, en ensayos cl\u00ednicos, la capacidad de restaurar la visi\u00f3n en pacientes con enfermedades retinianas y p\u00e9rdida visual severa. Nanoscope ha desarrollado MCO-010, la primera y \u00fanica tecnolog\u00eda optogen\u00e9tica de amplio espectro, respuesta r\u00e1pida y ultrasensible para la restauraci\u00f3n de la visi\u00f3n, independiente del gen.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2025\/03\/27\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2025\/03\/27\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nanostherapeutics.com\/2025\/03\/27\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_Ashish_V2_REV.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_LI_Ashish_V2_REV.jpg","width":1200,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2025\/03\/27\/ashish-patel-phd-joins-nanoscope-as-senior-vice-president-of-sales-and-marketing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Pharmaceutical Industry Veteran, Ashish Patel, PhD, Joins Nanoscope as Senior Vice President of Sales and Marketing"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"Terap\u00e9utica del nanoscopio","description":"Recuperando la luz de la esperanza","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"Nanoscope Therapeutics, Inc","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"Terap\u00e9utica del nanoscopio"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/es\/wp-json\/wp\/v2\/posts\/5987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/es\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/es\/wp-json\/wp\/v2\/comments?post=5987"}],"version-history":[{"count":8,"href":"https:\/\/nanostherapeutics.com\/es\/wp-json\/wp\/v2\/posts\/5987\/revisions"}],"predecessor-version":[{"id":7308,"href":"https:\/\/nanostherapeutics.com\/es\/wp-json\/wp\/v2\/posts\/5987\/revisions\/7308"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/es\/wp-json\/wp\/v2\/media\/5988"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/es\/wp-json\/wp\/v2\/media?parent=5987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/es\/wp-json\/wp\/v2\/categories?post=5987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/es\/wp-json\/wp\/v2\/tags?post=5987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}